Indoco's Goa facility - Plant III receives EU GMP certification from the German Health Authority

Indoco Remedies received EU GMP certification from the Competent Health Authority of Germany for its manufacturing site situated at L-32/33/34 Verna Industrial Estate, Goa. The European Agency conducted an inspection at Indoco's manufacturing facility for solid oral dosage form in Goa (Plant -III) from April 20-25, 2023.

The EU GMP certification issued by the German Health Authority (LAGeSo) confirms that the site complies with the Good Manufacturing Practice requirements as referred to in the EC Directive. The EU certification will support supplies of drug products registered in Europe and other regions from this manufacturing site.

Commenting on the development, Ms. Aditi Panandikar, Managing Director - Indoco Remedies Ltd. said, "The EU GMP certification for our site in Goa (Plant - III) complements our unswerving efforts to supply quality and affordable medicines in Europe and other geographies. We remain fully committed to adhering to cGMP standards and ensuring the delivery of quality products to our valued customers and patients worldwide."

Shares of Indoco Remedies Limited was last trading in BSE at Rs. 322.75 as compared to the previous close of Rs. 321.45. The total number of shares traded during the day was 17697 in over 1325 trades.

The stock hit an intraday high of Rs. 331.50 and intraday low of 317.95. The net turnover during the day was Rs. 5725745.00.

Source : Equity Bulls

Keywords

IndocoRemedies INE873D01024 EUGMPCertification Goa Plant3 GermanHealthAuthority